Engineered Extracellular Vesicle‐Delivered CRISPR/CasRx as a Novel RNA Editing Tool
Abstract Engineered extracellular vesicles (EVs) are considered excellent delivery vehicles for a variety of therapeutic agents, including nucleic acids, proteins, drugs, and nanomaterials. Recently, several studies have indicated that clustered regularly interspaced short palindromic repeats (CRISP...
Main Authors: | Tianwen Li, Liansheng Zhang, Tao Lu, Tongming Zhu, Canbin Feng, Ni Gao, Fei Liu, Jingyu Yu, Kezhu Chen, Junjie Zhong, Qisheng Tang, Quan Zhang, Xiangyang Deng, Junwei Ren, Jun Zeng, Haibo Zhou, Jianhong Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-04-01
|
Series: | Advanced Science |
Subjects: | |
Online Access: | https://doi.org/10.1002/advs.202206517 |
Similar Items
-
Methods for in vitro CRISPR/CasRx-Mediated RNA Editing
by: Yu-Fan Chuang, et al.
Published: (2021-06-01) -
RNA-Targeting CRISPR/CasRx system relieves disease symptoms in Huntington’s disease models
by: Yingqi Lin, et al.
Published: (2025-01-01) -
Specific knockdown of Htra2 by CRISPR-CasRx prevents acquired sensorineural hearing loss in mice
by: Yang Guo, et al.
Published: (2022-06-01) -
CRISPR/CasRx Proof-of-Concept for RNA Degradation: A Future Tool against RNA Viruses?
by: Diana Perez-SanJose, et al.
Published: (2021-12-01) -
Downregulation of Ripk1 and Nsf mediated by CRISPR-CasRx ameliorates stroke volume and neurological deficits after ischemia stroke in mice
by: Xincheng Song, et al.
Published: (2024-06-01)